Abstract: We disclose an in-toilet urinalysis system which includes a system for collection urine and for analysis of urine components using aptamer technology. Urine collection system may dispense urine into cuvettes, channels, or other containers that include aptamers. The aptamers may detect target molecules in urine. The aptamers may measure urine analytes, detect excreted drugs or drug metabolites, or disease markers. Upon binding to the target molecule, the aptamers may produce a signal which a sensor in the toilet may detect. In some embodiments, the signal may be electrochemical, fluorescent, or colorimetric. The measurements obtained from analysis of the urine may be used to assess a user's health or diagnose disease. In some embodiments, the measurements are stored in a controller which may transmit the measurements to a healthcare provider for assessment.

Abstract: The inventory management system (“the system”) includes a series of bar codes and a bar code reader. The bar codes are placed around the inventory storage area on or near containers which store inventory items. The bar codes identify the contents of the container. The system includes a bar code reader and an augmented reality viewing device. The system includes a processor which stores instructions for identifying the bar codes associated with each of the inventory items in an order. When the bar code reader scans a bar code associated with an item in the order, the augmented reality viewing device emits a cue that indicates the item should be picked. The containers may be connected to sensors which detect when an item has been removed and which transmit the sensor data to a processor. The processor may include instructions for processing the sensor data to maintain a current inventory.

Abstract: A healthcare-monitoring system collects health data through sensors then analyzes the data. The system may then instruct the user to retrieve one or more medical devices or tests stored within the system and perform an additional diagnostic measurement or test. Medication may also be stored within the system. The location of a medical device, test, or medication may be tracked in relation to the position of the user and the user's body parts. Correct use of the medical device or test and consumption of the medication may be assessed. A user interface may provide instruction for proper use of a medical device or test as well as its location within the system. Sensors may indicate whether a medical device has been returned to its proper place or if a consumable medical product has been removed from storage. The system may automatically reorder consumable medical supplies and track drug compliance.

Abstract: We disclose an in-toilet urinalysis system which includes a system for collection urine and for analysis of urine components using aptamer technology. Urine collection system may dispense urine into cuvettes, channels, or other containers that include aptamers. The aptamers may detect target molecules in urine. The aptamers may measure urine analytes, detect excreted drugs or drug metabolites, or disease markers. Upon binding to the target molecule, the aptamers may produce a signal which a sensor in the toilet may detect. In some embodiments, the signal may be electrochemical, fluorescent, or colorimetric. The measurements obtained from analysis of the urine may be used to assess a user's health or diagnose disease. In some embodiments, the measurements are stored in a controller which may transmit the measurements to a healthcare provider for assessment.

Abstract: The navigation system includes a series of bar codes and a bar code reader. The bar codes are placed at positions throughout the area to be navigated. The bar code readers scan the bar codes as a user moves through the area to be navigated. The navigation system may include a processor which includes instructions for receiving the user's current position and at least one location the user wishes to reach. The processor assembles the most efficient route from the user's position to the locations the user wishes to reach. The navigation system may include an augmented reality viewing device which receives signals from the processor and displays an augmented reality view to the user. The augmented reality view includes augmented reality images which provide step-by-step instructions from the user's position to the locations the user wishes to reach.

Abstract: The inventory management system (“the system”) includes a series of bar codes and a bar code reader. The bar codes are placed around the inventory storage area on or near containers which store inventory items. The bar codes identify the contents of the container. The system includes a bar code reader and an augmented reality viewing device. The system includes a processor which stores instructions for identifying the bar codes associated with each of the inventory items in an order. When the bar code reader scans a bar code associated with an item in the order, the augmented reality viewing device emits a cue that indicates the item should be picked. The containers may be connected to sensors which detect when an item has been removed and which transmit the sensor data to a processor. The processor may include instructions for processing the sensor data to maintain a current inventory.

Abstract: We disclose a method of tagging nutritional or drug compositions using chemical entities which are known to be safely consumed and which are detectable using known techniques, including near IR spectroscopy. The chemical entities used as tags may be detected in easily obtainable biological samples, including urine and feces. The biological sample may be deposited into a medical toilet which may analyze the biological sample using an analytical device associated with the medical toilet. The tag may be identified and quantified to then identify and quantify the nutritional or drug composition the subject consumed along with the tag. This system may be used to track the source of a food or drug, confirm compliance to a prescribed diet or drug treatment, confirm drug consumption in clinical trials, identify the source of contaminated food, and identify the food substances used to produce food products.

Abstract: The navigation system includes a series of bar codes and a bar code reader. The bar codes are placed at positions throughout the area to be navigated. The bar code readers scan the bar codes as a user moves through the area to be navigated. The navigation system may include a processor which includes instructions for receiving the user's current position and at least one location the user wishes to reach. The processor assembles the most efficient route from the user's position to the locations the user wishes to reach. The navigation system may include an augmented reality viewing device which receives signals from the processor and displays an augmented reality view to the user. The augmented reality view includes augmented reality images which provide step-by-step instructions from the user's position to the locations the user wishes to reach.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.

Abstract: We disclose a telemedicine device for tracking, dispensing, and retrieving medical supplies as well as methods of its use. The device includes a medical supply dispensing and retrieving station which includes a medical supply dispenser and medical supply receptacle. Both the medical supply dispenser and medical supply receptacle may include multiple compartments which house medical supplies. The device may include a communication port for receiving prescription information. The device includes a personal identification indicator which verifies the identity of the user and links the identity to the user's prescription information. The device may include medical devices. The medical devices may conduct measurements to confirm efficacy of a medical supply or screen for side effects. The device may confirm proper usage of a medical supply by weighing an unused portion of the medical supply and comparing it to the weight expected for the amount that should be remaining.

Abstract: The health-monitoring system includes one or more cameras which collect graphic data and a controller which calculates body proportion measurements based on the graphic data. Specifically, the health-monitoring system measures a user's body parts and their relative positions. These measurements may be combined with those collected by other devices and sensors within the system which conduct other health-related measurements. The other devices and sensors may be housed within a container and a least one of the cameras may also be housed within the container. In some embodiments, the container is a fixture, such as a bathroom medicine cabinet . The camera may be invisible to a user as positioned within the fixture. Consequently, the user may move and behave normally without changes which may occur due to being self-conscious of the camera. Calculations may occur within the controller or on a remote server to which data is transmitted.

Abstract: The method uses mass compute resources which are typically not in use to identify novel alloys. Owners of compute resources are offered a contract agreeing that the owner will receive a defined amount of a digital currency in exchange for the use of their compute resources. The digital currency may be managed using a blockchain ledger. The compute resources may be consumer devices which the user agrees to offer for use to develop alloys when the owner is not using the device. Academics and other entities may pay to select each group of elements to submit for computation. Profits realized by commercializing the alloys may be reinvested to fund the continued use of the method. The large amount of compute resources may be used to create a phase diagram for novel alloys in an amount of time that would otherwise be impossible.

Abstract: We disclose a drug tracking system and method of use which may be used to screen a subject's bodily waste in order to assess whether the subject has consumed a drug. The system includes a drug composition which is tagged with at least one artificial sweetener that may be detected in the subject's bodily waste. The subject may consume the tagged drug and a user may obtain a sample of the subject's bodily waste. The bodily waste sample may be analyzed to detect the artificial sweetener or its metabolite. In some embodiments, the result of the analysis of bodily waste may be entered into a database, compared to standards that comprises analyses of a plurality of drug tags, and the identity of the drug tag, and consequently the drug composition, determined.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, moisture, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.

Abstract: We disclose a method of tagging a variety of pharmaceutical or nutritional products in which well-studied chemicals may be added to the products in unique ratios. The identities of the chemicals and their relative ratios comprise unique taggants. The taggants may identify which of multiple distinct categories the product falls within. The method includes the step of systematically varying the relative concentrations of the chemicals resulting in multiple ratios of the chemicals. The plurality of ratios of a defined set of chemicals may be collected to form a library of taggants associated with specified items or categories. As the number of chemicals added per product increases, the library supports more categories and the system is less likely to produce a false positive. The method may result in a series of taggants for each item which is single fault tolerant or double fault tolerant.

Abstract: We disclose a tag for tracking and identifying pharmaceutical and nutritional products. The tag includes a paramagnetic microparticle which is connected to at least one unique and detectable chemical. The chemical may be coated on the paramagnetic microparticle or connected through functional groups. The tags may be too large to be taken into the bloodstream and therefore remain in the user's gastrointestinal tract. The tags may be fully or partially isolated from feces for analysis. The tags are attracted to an external electromagnetic force but are not magnetically attracted to each other. Consequently, the tags are safe to ingest. The tags may vary in volume or mass so as to be separable according to mass. The tags may be non-spherical in shape thus increasing the surface area to volume ratio and increasing the amount of chemical which may be attached as a taggant.

Abstract: We disclose an in-toilet urinalysis system which includes a system for collection urine and for analysis of urine components using aptamer technology. Urine collection system may dispense urine into cuvettes, channels, or other containers that include aptamers. The aptamers may detect target molecules in urine. The aptamers may measure urine analytes, detect excreted drugs or drug metabolites, or disease markers. Upon binding to the target molecule, the aptamers may produce a signal which a sensor in the toilet may detect. In some embodiments, the signal may be electrochemical, fluorescent, or colorimetric. The measurements obtained from analysis of the urine may be used to assess a user's health or diagnose disease. In some embodiments, the measurements are stored in a controller which may transmit the measurements to a healthcare provider for assessment.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition has decayed in response to environmental conditions and time. The taggants may decay in response to environmental conditions which cause drugs to lose their efficacy. The decay may occur due to improper storage or excursions into certain environmental conditions. These environmental conditions may include light, temperature, moisture, oxidation, and age. By including taggants that have different decay characteristics, the environmental condition that caused the decay may be determined. The amount of time the drug composition was exposed to the environmental condition and the amount of effective drug remaining may also be determined. The disclosed method may reduce the need for a unique assay for each drug to assess decay and determine shelf life. The disclosed method may also be used as a quality control technique for pharmaceutical products.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.

Abstract: We disclose a method of tagging nutritional or drug compositions using chemical entities which are known to be safely consumed and which are detectable using known techniques, including near IR spectroscopy. The chemical entities used as tags may be detected in easily obtainable biological samples, including urine and feces. The biological sample may be deposited into a medical toilet which may analyze the biological sample using an analytical device associated with the medical toilet. The tag may be identified and quantified to then identify and quantify the nutritional or drug composition the subject consumed along with the tag. This system may be used to track the source of a food or drug, confirm compliance to a prescribed diet or drug treatment, confirm drug consumption in clinical trials, identify the source of contaminated food, and identify the food substances used to produce food products.